In contrast, stroke induced a significant increase in maximal circulating concentrations of C1q (Figure 3A), C5 (Figure 3D) and C9 (Figure 3E) in both IL-1Ra and placebo treated patients measured in the first seven days after stroke in comparison to non-stroke controls. This evidence concerns the gene C5 and stroke disorder.